We found that CD8+ T cells in ICH patients mainly differentiated toward the CD8_GNLY subpopulation, particularly in hematoma samples, whereas CD8+ T cells in controls were mainly retained in the naïve CD8_SELL state (Fig. 2D). This evidence concerns the gene CD8A and hematoma.